These findings suggest that the identified genes involved in the miR-193a-3p/HOXC9/DNA damage response/oxidative stress pathway can serve as predictive of bladder cancer chemotherapy response [60]. The gene discussed is HOXC9; the disease is urinary bladder cancer.